REVIEW THE LATEST EVIDENCE
Oct
18-21
American Thyroid Association
87th Annual Meeting
Victoria, BC
Find Us at Booth 9
Afirma at ATA 2017

Development and Validation of Classifiers to Enhance the Afirma Genomic Sequencing Classifier Performance Among Hürthle Cell Specimens Saturday, October 21 | 9:00 AM PT

Interview with Quan-Yang Duh, M.D., University of California San Francisco

Read More >>
Clinical Validation of the Afirma Genomic Sequencing Classifier for Medullary Thyroid Cancer Saturday, October 21 | 4:00 PM PT

Interview with Gregory Randolph, M.D., Harvard Medical School

Read More >>
Clinical Validation of the Afirma Genomic Sequencing BRAF V600E Classifier Thursday, October 19 | 10:00 AM PT

Interview with Trevor E. Angell, M.D., Brigham and Women’s Hospital and Harvard Medical School

Read More >>
Clinical Validation of the Afirma Genomic Sequencing Parathyroid Classifier Thursday, October 19 | 10:00 AM PT

Interview with Richard T Kloos, M.D., Veracyte, Inc.

Read More >>
Analytical Performance of Afirma GSC: A Genomic Sequencing Classifier for Cytology-Indeterminate Thyroid Nodule FNA Specimens Friday, October 20 | 10:00 AM PT

Interview with Zhanzhi (Mike) Hu, Associate Director of Product Development, Veracyte, Inc.

Read More >>




NOT ATTENDING?

Call: 877-754-1047 to offer Afirma GSC to your patients
Follow the action at AACE
Visit us at ATA Booth 9 or call 888-923-4762 to begin integrating Afirma GSC into your practice now.